Safety and tolerability of Meningococcus B vaccine in patients with chronical medical conditions (CMC)
Abstract Background Invasive meningococcal disease is a serious global health threat in the world; in 2016, the European Centre for Disease Control and Prevention reported 3280 confirmed cases (including 304 deaths) of Invasive Meningococcal Diseases in Europe. In Italy, in 2017 were reported 200 ca...
Saved in:
Main Authors: | L. Nicolosi (Author), C. Rizzo (Author), G. Castelli Gattinara (Author), N. Mirante (Author), E. Bellelli (Author), C. Bianchini (Author), V. Pansini (Author), A. Villani (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2019-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Where next? The emergence of hypervirulent W meningococcus in the Netherlands
by: Jonathan Broad, et al.
Published: (2017) -
The Course of Generalized Meningococcal Infection Caused by Meningococcus Serogroup W135
by: M. V. Ivanova, et al.
Published: (2016) -
Policies for the immunization against serogroup B meningococcus for adolescents immunized during the first two years of life: A mini review
by: Claudia Palmieri, et al.
Published: (2024) -
Risk factors for carriage of meningococcus in third-level students in Ireland: an unsupervised machine learning approach
by: Richard J. Drew, et al.
Published: (2021) -
Varicella associated pneumoniae in a pediatric population
by: Elena Bozzola, et al.
Published: (2017)